Basic Information
Pathalys is a privately held, late-stage clinical biopharmaceutical company dedicated to developing a range of advanced therapies to address unmet needs in the management of late-stage chronic kidney disease (CKD).
Pathalys Pharma, Inc.
NorthCarolina,United States of America
less than 15 people
January 01, 2021
info@pathalys.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios